Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorProcare Health Iberia S.L.

About this trial

This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

- Women diagnosed with postmenopausal OP.

- Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca/D supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study.

- Women who had given their written informed consent before participating in the study.

Disqualifiers

None

Trial population

Women with postmenopausal osteoporosis who have been prescribed treatment with an oral bisphosphonate combined with Ca/D supplements.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Intergroup adherence

To evaluate intergroup adherence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements, using a 8-items Morisky Medication Adherence Scale

Time frame
Day 1

Secondary outcomes

1

Persistence intergroup

To evaluate, intergroup, the persistence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements. It will be evaluated over time from the start of the combination of both until the first end date of administration of either one, and by the percentage of patients who continue with the combined treatment since its prescription

Time frame
Day 1
2

Adherence intragroup

To evaluate, intragroup, the adherence to the prescribed usual oral regimens, using a 8-items Morisky Medication Adherence Scale

Time frame
Day 1
3

Persistence intragroup

To evaluate, intragroup, the persistence to the prescribed usual oral regimens.

Time frame
Day 1
4

Factors of non-adherence

To evaluate possible determining factors of non-adherence to the prescribed usual oral regimens and their comparison between the different regimens.

Time frame
Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.